China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy, Safety, and Patient-Reported Outcomes of Oxycodone Sustained-Release Tablets in Patients with Solid Tumor-Related Cancer Pain: A Multicenter, Prospective Real-World Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132163

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: Nanxishan Hospital of Guangxi Zhuang Autonomous Region

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332432

Published by HT Digital Content Services with permission from Health Daily Digest....